Combatting the Normalization of Illegal Cigarette Purchases in Adults

Jul.09.2024

Research by Japan Tobacco International reveals a normalization of illegal cigarette purchases in countries including the Philippines, France, UK, and Canada.

According to a study conducted by Japan Tobacco International (referred to as JTI), the purchase of illegal cigarettes has become increasingly normalized among adult smokers in the Philippines, as well as in France, the UK, and Canada. Governments and relevant agencies worldwide need to be highly vigilant of this trend and promptly implement effective measures to combat the illegal tobacco market.

Research data shows that approximately 33% of adult smokers in the Philippines are willing to purchase illicit tobacco, while about 43% of surveyed smokers say they are "willing to buy tobacco they know is illegally produced or sold." So far, the government has lost around 7 billion pesos (1.2 billion USD) due to illegal cigarettes and e-cigarette products.

Japan Tobacco International (JTI) has stated that they will continue their efforts to combat illegal tobacco trade. They plan to closely collaborate with relevant organizations worldwide and actively educate the public about the dangers of illicit cigarettes. JTI also aims to gain more support and assistance from governments and relevant agencies in order to collectively combat the illegal tobacco market and keep adult smokers around the world away from illegal cigarettes.

References:

[1] JTI: One third of Filipino smokers accept illicit cigarettes

Also Read:

[1] DTI to Reduce SRP Monitoring List, Suspend E-cigarette Sales

[2] Government struggles with loss of revenue from illegal e-cigarette sales

[3] Joint Efforts to Combat Illegal E-cigarette Products in Philippines

#Europe #Traditional tobacco #France #Public opinion.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Japan Unveils Limited-Edition IQOS ILUMA i “Galaxy Blue,” Priced Around $47

Philip Morris Japan announced it will release the limited-edition IQOS ILUMA i “Galaxy Blue” across IQOS stores nationwide starting October 29, priced at JPY 6,980 including tax (about USD 47). The new model features a space-themed design, with a members-only promotion to run at the Nagoya IQOS store.

Oct.29 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council

Belgian Health Minister Frank Vandenbroucke has announced plans to ban all e-cigarette flavours except tobacco, following new advice from the Superior Health Council (CSS). The move marks a major policy shift, as the Council now fully supports flavour restrictions to curb youth vaping.

Nov.19 by 2FIRSTS.ai

2Firsts Co-Founder and CEO Alan Zhao Speaks at PouchEX 2025: Highlighting China’s Critical Role in the Global Nicotine Pouch Industry

At PouchEX 2025 in Sweden, 2Firsts CEO Alan Zhao delivered an invited keynote, outlining China’s critical role in the global nicotine pouch industry from both supply chain and consumer insight perspectives, drawing significant attention from the international community.